RT Journal Article
SR Electronic
T1 Identifying the Factor Structure of the DSM-5 Level 1 Cross-Cutting Symptom Measure
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.28.21256253
DO 10.1101/2021.04.28.21256253
A1 Gibbons, Alison
A1 Farmer, Cristan
A1 Shaw, Jacob
A1 Chung, Joyce Y
YR 2021
UL http://medrxiv.org/content/early/2021/05/01/2021.04.28.21256253.abstract
AB The DSM-5 Level 1 Cross-Cutting Symptom Measure (DSM-XC) is a transdiagnostic mental health symptom measure that has shown promise in informing clinical diagnostic evaluations and as a screening tool for research. However, few studies have assessed the latent dimensionality of the DSM-XC or provided guidance on how to score the survey. In this report, we examined the factor structure of the DSM-XC in a sample of over 3500 participants enrolled in a protocol on the mental health impact of COVID-19 conducted through the National Institute of Mental Health Intramural Research Program (NIMH IRP) (ClinicalTrials.gov identifier: NCT04339790). We began by conducting an exploratory factor analysis (EFA) to identify the best solution for our data, and then employed a confirmatory factor analyses (CFAs) to evaluate the fit of the two-factor solution proposed by Lace and Merz (Lace & Merz, 2020), the fit of our proposed solution, and the measurement invariance of our proposed solution across age, sex, and calendar time. We found a six-factor solution stemming from our EFAs to best fit our data. Each factor captures symptoms related to a specific construct of psychopathology: mood, worry, activation, somatic, confusion, and substance use. Future research should evaluate this six-factor structure using additional datasets to confirm its consistency across research populations and settings.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04339790Clinical Protocols https://nimhcovidstudy.ctss.nih.gov/ Funding StatementThe research was funded by the Intramural Research Program of the National Institute of Mental Health (ZIAMH002922). The sponsor had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:These data were collected as part of a NIMH study that was carried out in accordance with the latest version of the Declaration of Helsinki and was approved by the Institutional Review Board of the National Institutes of Health. For this purpose of this report, we will primarily focus on methodology relevant to the collection of the DSM-XC survey data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA NIMH Data Sharing form has been completed and submitted in accordance with the NIH Intramural Research policy on broad sharing of NIH research data.These data will be made available after publication of study findings.